Tactile Systems Technology, Inc. (TCMD)
Market Cap | 449.71M |
Revenue (ttm) | 285.05M |
Net Income (ttm) | 15.45M |
Shares Out | 24.00M |
EPS (ttm) | 0.65 |
PE Ratio | 28.97 |
Forward PE | 24.79 |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 109,235 |
Open | 18.50 |
Previous Close | 18.59 |
Day's Range | 18.11 - 18.86 |
52-Week Range | 11.12 - 21.10 |
Beta | 1.20 |
Analysts | Hold |
Price Target | n/a |
Earnings Date | Nov 4, 2024 |
About TCMD
Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Kylee, a mobile application to help patients learn a... [Read more]
Financial Performance
Financial StatementsNews
Tactile Medical to Present at the Piper Sandler 36th Annual Healthcare Conference
MINNEAPOLIS, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chro...
Tactile Systems Technology, Inc. (TCMD) Q3 2024 Earnings Call Transcript
Tactile Systems Technology, Inc. (NASDAQ:TCMD) Q3 2024 Earnings Conference Call November 4, 2024 5:00 PM ET Company Participants Sam Bentzinger - Investor Relations, Gilmartin Group LLC Sheri Dodd - ...
Tactile Systems Technology, Inc. Reports Third Quarter 2024 Financial Results
MINNEAPOLIS, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chro...
Tactile Medical to Release Third Quarter of Fiscal Year 2024 Financial Results on November 4, 2024
MINNEAPOLIS, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chro...
Tactile Medical Launches Next-Generation Nimbl™ Lymphedema Platform
Initial Launch Focused on Treating Patients Suffering from Upper Extremity Lymphedema Initial Launch Focused on Treating Patients Suffering from Upper Extremity Lymphedema
UPDATE -- Tactile Medical Announces Positive Clinical Trial Results in Lymphedema Patients Using Advanced Pneumatic Compression Device Therapy
Largest U.S. Prospective Clinical Trial Ever Conducted Demonstrated High Compliance with the Flexitouch® System and Significant Improvements Across Study Endpoints Largest U.S. Prospective Clinical Tr...
Tactile Systems Technology, Inc. (TCMD) Q2 2024 Earnings Call Transcript
Tactile Systems Technology, Inc. (NASDAQ:TCMD) Q2 2024 Earnings Conference Call August 5, 2024 5:00 PM ET Company Participants Sam Bentzinger - Investor Relations, Gilmartin Group LLC Sheri Dodd - Ch...
Tactile Systems Technology, Inc. Reports Second Quarter 2024 Financial Results
MINNEAPOLIS, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chro...
Tactile Medical to Release Second Quarter of Fiscal Year 2024 Financial Results on August 5, 2024
MINNEAPOLIS, July 22, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chro...
Tactile Medical to Present at the William Blair 44th Annual Growth Stock Conference
MINNEAPOLIS, May 21, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chron...
Tactile Systems Technology, Inc. (TCMD) Q1 2024 Earnings Call Transcript
Tactile Systems Technology, Inc. (NASDAQ:TCMD) Q1 2024 Earnings Conference Call May 6, 2024 5:00 PM ET Company Participants Sam Bentzinger – Investor Relations-Gilmartin Group LLC Dan Reuvers – Presi...
Tactile Systems Technology, Inc. Reports First Quarter 2024 Financial Results
MINNEAPOLIS, May 06, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chron...
Tactile Medical Announces CEO Transition and Preliminary First Quarter 2024 Revenue
MINNEAPOLIS, April 23, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chr...
Tactile Medical to Release First Quarter of Fiscal Year 2024 Financial Results on May 6, 2024
MINNEAPOLIS, April 15, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chr...
Tactile Systems Technology (TCMD) Q4 2023 Earnings Call Transcript
Tactile Systems Technology (TCMD) Q4 2023 Earnings Call Transcript
Tactile Systems Technology, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Outlook
Full Year Revenue Increased 11% Year-Over-Year; Full Year Net Income Increased 260%; Full Year Adjusted EBITDA Increased 62% Full Year Revenue Increased 11% Year-Over-Year; Full Year Net Income Increa...
Tactile Medical to Participate in Upcoming Investor Conferences in February and March
MINNEAPOLIS, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, ...
Tactile Medical to Release Fourth Quarter and Fiscal Year 2023 Financial Results on February 20, 2024
MINNEAPOLIS, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chro...
Tactile Systems Technology, Inc. (TCMD) Q3 2023 Earnings Call Transcript
Tactile Systems Technology, Inc. (NASDAQ:TCMD) Q3 2023 Earnings Call Transcript November 6, 2023 5:00 PM ET Company Participants Daniel Reuvers - President & Chief Executive Officer Elaine Birkemeyer...
Tactile Systems Technology, Inc. Reports Third Quarter 2023 Financial Results; Updates Full Year 2023 Outlook
MINNEAPOLIS, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chro...
Tactile Medical to Release Third Quarter of Fiscal Year 2023 Financial Results on November 6, 2023
MINNEAPOLIS, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chro...
Tactile Medical Appoints Vindell Washington, M.D. to Board of Directors
MINNEAPOLIS, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, ...
Tactile Medical to Participate in Two Upcoming Conferences in September
MINNEAPOLIS, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chr...
Tactile Medical to Present at the 2023 Wells Fargo Healthcare Conference
MINNEAPOLIS, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chro...
Tactile Systems Technology, Inc. (TCMD) Q2 2023 Earnings Call Transcript
Tactile Systems Technology, Inc. (NASDAQ:TCMD) Q2 2023 Earnings Conference Call August 7, 2023 5:00 PM ET Company Participants Daniel Reuvers - President & Chief Executive Officer Elaine Birkemeyer -...